In the U.S., as many as 170,000 people are living with a group of bone marrow disorders called myelodysplastic syndromes (MDS), in which the body does not produce enough healthy blood cells.
Low blood cell counts in people with MDS are responsible for common symptoms of the disease, including anemia.
Now there's a new hope for those living with anemia caused by MDS. Reblozyl is an injection that helps patients who need regular red blood cell transfusions. Transfusions are time consuming and cumbersome, and while the medication is not a substitute for a transfusion, patients may need them less often.
Learn more about Reblozyl here.
Learn more about MDS here.